-
1
-
-
84894797638
-
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
-
COI: 1:CAS:528:DC%2BC3sXht1ygur3K, PID: 23898968
-
Fredly H, Gjertsen B, Bruserud Ø. Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents. Clin Epigenetics. 2013;5:12.
-
(2013)
Clin Epigenetics.
, vol.5
, pp. 12
-
-
Fredly, H.1
Gjertsen, B.2
Bruserud, Ø.3
-
2
-
-
33750596313
-
Epigenetic cancer therapy makes headway
-
PID: 17047192
-
Mack GS. Epigenetic cancer therapy makes headway. J Natl Cancer Inst. 2006;98:1443–4.
-
(2006)
J Natl Cancer Inst.
, vol.98
, pp. 1443-1444
-
-
Mack, G.S.1
-
3
-
-
33744956666
-
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
-
COI: 1:CAS:528:DC%2BD28Xkt1ymt7Y%3D, PID: 16533812
-
Wilson AJ, Byun DS, Popova N, Murray LB, L'Italien K, Sowa Y, et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem. 2006;281:13548–58.
-
(2006)
J Biol Chem.
, vol.281
, pp. 13548-13558
-
-
Wilson, A.J.1
Byun, D.S.2
Popova, N.3
Murray, L.B.4
L'Italien, K.5
Sowa, Y.6
-
4
-
-
67650090545
-
Histone deacetylase inhibitors: potential in cancer therapy
-
COI: 1:CAS:528:DC%2BD1MXosFOiurg%3D, PID: 19459166
-
Marks PA, Xu W-S. Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem. 2009;107:600–8.
-
(2009)
J Cell Biochem.
, vol.107
, pp. 600-608
-
-
Marks, P.A.1
Xu, W.-S.2
-
5
-
-
84860257685
-
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
-
COI: 1:CAS:528:DC%2BC38XmtlyqtbY%3D, PID: 22414492
-
Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics. 2012;4:5.
-
(2012)
Clin Epigenetics.
, vol.4
, pp. 5
-
-
Delcuve, G.P.1
Khan, D.H.2
Davie, J.R.3
-
6
-
-
31544436888
-
Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?
-
COI: 1:CAS:528:DC%2BD28XmslyrtQ%3D%3D, PID: 16267097
-
Dashwood RH, Myzak MC, Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis. 2006;27:344–9.
-
(2006)
Carcinogenesis.
, vol.27
, pp. 344-349
-
-
Dashwood, R.H.1
Myzak, M.C.2
Ho, E.3
-
7
-
-
84860238020
-
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
-
COI: 1:CAS:528:DC%2BC3MXhsFSrur%2FN, PID: 22247744
-
Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics. 2011;3:4.
-
(2011)
Clin Epigenetics.
, vol.3
, pp. 4
-
-
Rajendran, P.1
Ho, E.2
Williams, D.E.3
Dashwood, R.H.4
-
8
-
-
79956362344
-
Metabolism as a key to histone deacetylase inhibition
-
COI: 1:CAS:528:DC%2BC3MXmtl2ksLg%3D, PID: 21599534
-
Rajendran P, Williams DE, Ho E, Dashwood RH. Metabolism as a key to histone deacetylase inhibition. Crit Rev Biochem Mol Biol. 2011;46:181–99.
-
(2011)
Crit Rev Biochem Mol Biol.
, vol.46
, pp. 181-199
-
-
Rajendran, P.1
Williams, D.E.2
Ho, E.3
Dashwood, R.H.4
-
9
-
-
33644646401
-
Chemoprotection by sulforaphane: keep one eye beyond Keap1
-
COI: 1:CAS:528:DC%2BD28XitVCrur0%3D, PID: 16520150
-
Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett. 2006;233:208–18.
-
(2006)
Cancer Lett.
, vol.233
, pp. 208-218
-
-
Myzak, M.C.1
Dashwood, R.H.2
-
11
-
-
4143130097
-
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase
-
COI: 1:CAS:528:DC%2BD2cXmslaksr0%3D, PID: 15313918
-
Myzak MC, Karplus PA, Chung F-L, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 2004;64:5767–74.
-
(2004)
Cancer Res.
, vol.64
, pp. 5767-5774
-
-
Myzak, M.C.1
Karplus, P.A.2
Chung, F.-L.3
Dashwood, R.H.4
-
12
-
-
33846838750
-
Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects
-
COI: 1:CAS:528:DC%2BD2sXhsVWjt7g%3D
-
Myzak MC, Tong P, Dashwood W-M, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med. 2007;232:227–34.
-
(2007)
Exp Biol Med.
, vol.232
, pp. 227-234
-
-
Myzak, M.C.1
Tong, P.2
Dashwood, W.-M.3
Dashwood, R.H.4
Ho, E.5
-
13
-
-
0030931522
-
Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
-
COI: 1:CAS:528:DyaK2sXmt1GjsbY%3D, PID: 9294217
-
Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997;94:10367–72.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 10367-10372
-
-
Fahey, J.W.1
Zhang, Y.2
Talalay, P.3
-
14
-
-
0026577605
-
A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure
-
COI: 1:CAS:528:DyaK38Xls1egtro%3D, PID: 1549603
-
Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA. 1992;89:2399–403.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 2399-2403
-
-
Zhang, Y.1
Talalay, P.2
Cho, C.G.3
Posner, G.H.4
-
15
-
-
84874489560
-
Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane
-
COI: 1:CAS:528:DC%2BC3sXmsVaqsbs%3D, PID: 22752583
-
Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem. 2013;329:163–77.
-
(2013)
Top Curr Chem.
, vol.329
, pp. 163-177
-
-
Kensler, T.W.1
Egner, P.A.2
Agyeman, A.S.3
Visvanathan, K.4
Groopman, J.D.5
Chen, J.G.6
-
16
-
-
84880048347
-
Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis
-
COI: 1:CAS:528:DC%2BC3sXhtValu7zL, PID: 23610445
-
Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 2013;73:4158–68.
-
(2013)
Cancer Res.
, vol.73
, pp. 4158-4168
-
-
Satoh, H.1
Moriguchi, T.2
Takai, J.3
Ebina, M.4
Yamamoto, M.5
-
17
-
-
74049120454
-
Nrf2: friend or foe for chemoprevention?
-
COI: 1:CAS:528:DC%2BC3cXktlCgsQ%3D%3D, PID: 19793802
-
Kensler TW, Wakabayashi N. Nrf2: friend or foe for chemoprevention? Carcinogenesis. 2010;31:90–9.
-
(2010)
Carcinogenesis.
, vol.31
, pp. 90-99
-
-
Kensler, T.W.1
Wakabayashi, N.2
-
18
-
-
27644468268
-
How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men
-
COI: 1:CAS:528:DC%2BD2MXpslyitrk%3D, PID: 16084718
-
Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer. 2005;41:1911–22.
-
(2005)
Eur J Cancer.
, vol.41
, pp. 1911-1922
-
-
Corpet, D.E.1
Pierre, F.2
-
19
-
-
0025030412
-
Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds
-
COI: 1:CAS:528:DyaK3cXlt1KjtL8%3D, PID: 2379172
-
Sumiyoshi H, Wargovich MJ. Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res. 1990;50:5084–7.
-
(1990)
Cancer Res.
, vol.50
, pp. 5084-5087
-
-
Sumiyoshi, H.1
Wargovich, M.J.2
-
20
-
-
79957545769
-
Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly
-
COI: 1:CAS:528:DC%2BC3MXntVWrtr8%3D, PID: 21624135
-
Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer. 2011;10:68.
-
(2011)
Mol Cancer.
, vol.10
, pp. 68
-
-
Rajendran, P.1
Delage, B.2
Dashwood, W.M.3
Yu, T.W.4
Wuth, B.5
Williams, D.E.6
-
21
-
-
84891691403
-
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
-
COI: 1:CAS:528:DC%2BC2cXivFWksrg%3D, PID: 23770684
-
Rajendran P, Kidane AI, Yu TW, Dashwood WM, Bisson WH, Löhr CV, et al. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. Epigenetics. 2013;8:612–23.
-
(2013)
Epigenetics.
, vol.8
, pp. 612-623
-
-
Rajendran, P.1
Kidane, A.I.2
Yu, T.W.3
Dashwood, W.M.4
Bisson, W.H.5
Löhr, C.V.6
-
22
-
-
83555173511
-
Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice
-
COI: 1:CAS:528:DC%2BC3MXnsF2ltbg%3D, PID: 21681606
-
Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, et al. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res. 2011;28:3171–9.
-
(2011)
Pharm Res.
, vol.28
, pp. 3171-3179
-
-
Clarke, J.D.1
Hsu, A.2
Williams, D.E.3
Dashwood, R.H.4
Stevens, J.F.5
Yamamoto, M.6
-
23
-
-
68149182343
-
The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence
-
COI: 1:CAS:528:DC%2BD1MXpt1elt7c%3D, PID: 19583777
-
Feng Y, Wang X, Xu L, Pan H, Zhu S, Liang Q, et al. The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. FEBS J. 2009;276:4197–206.
-
(2009)
FEBS J.
, vol.276
, pp. 4197-4206
-
-
Feng, Y.1
Wang, X.2
Xu, L.3
Pan, H.4
Zhu, S.5
Liang, Q.6
-
24
-
-
50849120018
-
YY1 restrained cell senescence through repressing the transcription of p16
-
Wang X, Feng Y, Xu L, Chen Y, Zhang Y, Su D, et al. YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta. 1783;2008:1876–83.
-
(1783)
Biochim Biophys Acta.
, vol.2008
, pp. 1876-1883
-
-
Wang, X.1
Feng, Y.2
Xu, L.3
Chen, Y.4
Zhang, Y.5
Su, D.6
-
25
-
-
84863157663
-
Histone deacetylase 3 (HDAC3) participates in the transcriptional repression of the p16 (INK4a) gene in mammary gland of the female rat offspring exposed to an early-life high-fat diet
-
COI: 1:CAS:528:DC%2BC38XnsVKjtbs%3D, PID: 22395468
-
Zheng S, Li Q, Zhang Y, Balluff Z, Pan Y-X. Histone deacetylase 3 (HDAC3) participates in the transcriptional repression of the p16 (INK4a) gene in mammary gland of the female rat offspring exposed to an early-life high-fat diet. Epigenetics. 2012;7:183–90.
-
(2012)
Epigenetics.
, vol.7
, pp. 183-190
-
-
Zheng, S.1
Li, Q.2
Zhang, Y.3
Balluff, Z.4
Pan, Y.-X.5
-
26
-
-
18444392071
-
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia
-
COI: 1:CAS:528:DC%2BD38XkvFehtrs%3D, PID: 12091906
-
Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, et al. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med. 2002;8:743–50.
-
(2002)
Nat Med.
, vol.8
, pp. 743-750
-
-
Linggi, B.1
Müller-Tidow, C.2
van de Locht, L.3
Hu, M.4
Nip, J.5
Serve, H.6
-
27
-
-
84923953750
-
Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract
-
COI: 1:CAS:528:DC%2BC2MXhtFOitLo%3D, PID: 25522265
-
Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu TW, et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Mol Nutr Food Res. 2015;59:424–33.
-
(2015)
Mol Nutr Food Res.
, vol.59
, pp. 424-433
-
-
Atwell, L.L.1
Hsu, A.2
Wong, C.P.3
Stevens, J.F.4
Bella, D.5
Yu, T.W.6
-
28
-
-
34249877709
-
Increase in cruciferous vegetable intake in women previously treated for breast cancer participating in a dietary intervention trial
-
COI: 1:CAS:528:DC%2BD2sXnt1aktrg%3D, PID: 17516858
-
Thomson CA, Rock CL, Caan BJ, Flatt SW, Al-Delaimy WA, Newman VA, et al. Increase in cruciferous vegetable intake in women previously treated for breast cancer participating in a dietary intervention trial. Nutr Cancer. 2007;57:11–9.
-
(2007)
Nutr Cancer.
, vol.57
, pp. 11-19
-
-
Thomson, C.A.1
Rock, C.L.2
Caan, B.J.3
Flatt, S.W.4
Al-Delaimy, W.A.5
Newman, V.A.6
-
29
-
-
0034525122
-
Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate
-
COI: 1:CAS:528:DC%2BD3MXmsFyrtw%3D%3D, PID: 11133820
-
Chung FL, Conaway CC, Rao CV, Reddy BS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis. 2000;21:2287–91.
-
(2000)
Carcinogenesis.
, vol.21
, pp. 2287-2291
-
-
Chung, F.L.1
Conaway, C.C.2
Rao, C.V.3
Reddy, B.S.4
-
30
-
-
42549114401
-
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
-
COI: 1:CAS:528:DC%2BD1cXmt1antb4%3D, PID: 18194985
-
Glauben R, Batra A, Stroh T, Erben U, Fedke I, Lehr HA, et al. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut. 2008;57:613–22.
-
(2008)
Gut.
, vol.57
, pp. 613-622
-
-
Glauben, R.1
Batra, A.2
Stroh, T.3
Erben, U.4
Fedke, I.5
Lehr, H.A.6
-
31
-
-
33749581701
-
Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetables
-
COI: 1:CAS:528:DC%2BD28XhtVOmu7%2FI, PID: 16675473
-
Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, Chen C, et al. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetables. Carcinogenesis. 2006;27:2038–46.
-
(2006)
Carcinogenesis.
, vol.27
, pp. 2038-2046
-
-
Hu, R.1
Khor, T.O.2
Shen, G.3
Jeong, W.S.4
Hebbar, V.5
Chen, C.6
-
32
-
-
84890441806
-
Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation
-
COI: 1:CAS:528:DC%2BC38Xht1agsb7F, PID: 22911891
-
Cheung KL, Lee JH, Khor TO, Wu TY, Li GX, Chan J, et al. Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Mol Carcinog. 2014;53:77–84.
-
(2014)
Mol Carcinog.
, vol.53
, pp. 77-84
-
-
Cheung, K.L.1
Lee, J.H.2
Khor, T.O.3
Wu, T.Y.4
Li, G.X.5
Chan, J.6
-
33
-
-
33846264538
-
Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis
-
COI: 1:CAS:528:DC%2BD28XhtlagurjI, PID: 17178849
-
Khor TO, Huang M-T, Kwon KH, Chan JY, Reddy BS, Kong A-N. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006;66:11580–4.
-
(2006)
Cancer Res.
, vol.66
, pp. 11580-11584
-
-
Khor, T.O.1
Huang, M.-T.2
Kwon, K.H.3
Chan, J.Y.4
Reddy, B.S.5
Kong, A.-N.6
-
34
-
-
56249086316
-
Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
-
COI: 1:CAS:528:DC%2BC3cXptVyruro%3D
-
Khor TO, Huang MT, Prawan A, Liu Y, Hao X, Yu S, et al. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res. 2008;1:187–91.
-
(2008)
Cancer Prev Res.
, vol.1
, pp. 187-191
-
-
Khor, T.O.1
Huang, M.T.2
Prawan, A.3
Liu, Y.4
Hao, X.5
Yu, S.6
-
35
-
-
34648830424
-
Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment
-
COI: 1:CAS:528:DC%2BD2sXhtFSjsL7I, PID: 17631644
-
Osburn WO, Karim B, Dolan PM, Liu G, Yamamoto M, Huso DL, et al. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer. 2007;121:1883–91.
-
(2007)
Int J Cancer.
, vol.121
, pp. 1883-1891
-
-
Osburn, W.O.1
Karim, B.2
Dolan, P.M.3
Liu, G.4
Yamamoto, M.5
Huso, D.L.6
-
36
-
-
84864348569
-
NRF2 and cancer: the good, the bad, and the importance of context
-
COI: 1:CAS:528:DC%2BC38XhtVCltLjF, PID: 22810811
-
Sporn MB, Liby KT. NRF2 and cancer: the good, the bad, and the importance of context. Nat Rev Cancer. 2012;12:564–71.
-
(2012)
Nat Rev Cancer.
, vol.12
, pp. 564-571
-
-
Sporn, M.B.1
Liby, K.T.2
-
37
-
-
0033864579
-
Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis
-
COI: 1:CAS:528:DC%2BD3cXmtVWhurs%3D, PID: 10942530
-
Wang QS, Papanikolaou A, Nambiar PR, Rosenberg DW. Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis. Mol Carcinog. 2000;28:139–47.
-
(2000)
Mol Carcinog.
, vol.28
, pp. 139-147
-
-
Wang, Q.S.1
Papanikolaou, A.2
Nambiar, P.R.3
Rosenberg, D.W.4
-
38
-
-
79955636534
-
p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
-
COI: 1:CAS:528:DC%2BC3MXhsFyqur4%3D, PID: 21297668
-
Romagosa C, Simonetti S, López-Vicente L, Mazo A, Lleonart ME, Castellvi J, et al. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene. 2011;30:2087–97.
-
(2011)
Oncogene.
, vol.30
, pp. 2087-2097
-
-
Romagosa, C.1
Simonetti, S.2
López-Vicente, L.3
Mazo, A.4
Lleonart, M.E.5
Castellvi, J.6
-
39
-
-
77956530122
-
Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A
-
COI: 1:CAS:528:DC%2BC3cXht1Omu7zF, PID: 20811718
-
Chen M, Voeller D, Marquez VE, Kaye FJ, Steeg PS, Giaccone G, et al. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. Int J Oncol. 2010;37:963–71.
-
(2010)
Int J Oncol.
, vol.37
, pp. 963-971
-
-
Chen, M.1
Voeller, D.2
Marquez, V.E.3
Kaye, F.J.4
Steeg, P.S.5
Giaccone, G.6
-
40
-
-
75649134998
-
Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
-
COI: 1:CAS:528:DC%2BC3cXivFeqt7k%3D, PID: 19860841
-
Yamaguchi J, Sasaki M, Sato Y, Itatsu K, Harada K, Zen Y, et al. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma. Cancer Sci. 2010;101:355–62.
-
(2010)
Cancer Sci.
, vol.101
, pp. 355-362
-
-
Yamaguchi, J.1
Sasaki, M.2
Sato, Y.3
Itatsu, K.4
Harada, K.5
Zen, Y.6
-
41
-
-
34247324355
-
Valproic acid induces apoptosis, p16INK4A upregulation, and sensitization to chemotherapy in human melanoma cells
-
COI: 1:CAS:528:DC%2BD2sXhtVeqsbzJ, PID: 17218782
-
Valentini A, Gravina P, Federici G, Bernardini S. Valproic acid induces apoptosis, p16INK4A upregulation, and sensitization to chemotherapy in human melanoma cells. Cancer Biol Ther. 2007;6:185–91.
-
(2007)
Cancer Biol Ther.
, vol.6
, pp. 185-191
-
-
Valentini, A.1
Gravina, P.2
Federici, G.3
Bernardini, S.4
-
42
-
-
33750039375
-
Regulation of p16INK4a, senescence and oncogenesis
-
Chien WW, Ffrench M. Regulation of p16INK4a, senescence and oncogenesis. Med Sci. 2006;22:865–71.
-
(2006)
Med Sci.
, vol.22
, pp. 865-871
-
-
Chien, W.W.1
Ffrench, M.2
-
43
-
-
0035931859
-
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
-
COI: 1:CAS:528:DC%2BD3MXhs1Gjsbw%3D, PID: 11234019
-
Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001;409:1067–70.
-
(2001)
Nature.
, vol.409
, pp. 1067-1070
-
-
Ohtani, N.1
Zebedee, Z.2
Huot, T.J.3
Stinson, J.A.4
Sugimoto, M.5
Ohashi, Y.6
-
44
-
-
84863128509
-
The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression
-
COI: 1:CAS:528:DC%2BC38Xit1Ons7c%3D, PID: 21967847
-
Wang W, Pan K, Chen Y, Huang C, Zhang X. The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. Nucleic Acids Res. 2012;40:981–95.
-
(2012)
Nucleic Acids Res.
, vol.40
, pp. 981-995
-
-
Wang, W.1
Pan, K.2
Chen, Y.3
Huang, C.4
Zhang, X.5
-
45
-
-
74249120954
-
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model
-
COI: 1:CAS:528:DC%2BD1MXhs1Sqs7%2FK, PID: 19777566
-
Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, et al. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog. 2010;49:94–103.
-
(2010)
Mol Carcinog.
, vol.49
, pp. 94-103
-
-
Borinstein, S.C.1
Conerly, M.2
Dzieciatkowski, S.3
Biswas, S.4
Washington, M.K.5
Trobridge, P.6
-
46
-
-
84875404794
-
The UCSC Genome Browser database: extensions and updates 2013
-
COI: 1:CAS:528:DC%2BC38XhvV2ksbjE, PID: 23155063
-
Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 2013;41:D64–9.
-
(2013)
Nucleic Acids Res.
, vol.41
, pp. D64-D69
-
-
Meyer, L.R.1
Zweig, A.S.2
Hinrichs, A.S.3
Karolchik, D.4
Kuhn, R.M.5
Wong, M.6
-
47
-
-
77954672845
-
Epigenetic therapies move into new territory, but how exactly do they work?
-
PID: 19755677
-
Tuma RS. Epigenetic therapies move into new territory, but how exactly do they work? J Natl Cancer Inst. 2009;101(19):1300–1.
-
(2009)
J Natl Cancer Inst
, vol.101
, Issue.19
, pp. 1300-1301
-
-
Tuma, R.S.1
-
48
-
-
79953314094
-
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
-
COI: 1:CAS:528:DC%2BC3MXktVSgtr8%3D, PID: 20715105
-
Wang R, Dashwood WM, Nian H, Löhr CV, Fischer KA, Tsuchiya N, et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Int J Cancer. 2011;128:2581–90.
-
(2011)
Int J Cancer.
, vol.128
, pp. 2581-2590
-
-
Wang, R.1
Dashwood, W.M.2
Nian, H.3
Löhr, C.V.4
Fischer, K.A.5
Tsuchiya, N.6
-
49
-
-
51849103354
-
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
-
COI: 1:CAS:528:DC%2BD1cXhtV2jsLzJ, PID: 18628250
-
Nian H, Delage B, Pinto JT, Dashwood RH. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis. 2008;29:1816–24.
-
(2008)
Carcinogenesis.
, vol.29
, pp. 1816-1824
-
-
Nian, H.1
Delage, B.2
Pinto, J.T.3
Dashwood, R.H.4
-
50
-
-
84888882715
-
A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis
-
COI: 1:CAS:528:DC%2BC3sXitlKjsLc%3D, PID: 23006636
-
Parasramka M, Dashwood WM, Wang R, Saeed HH, Williams DE, Ho E, et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis. Clin Epigenetics. 2012;4:16.
-
(2012)
Clin Epigenetics.
, vol.4
, pp. 16
-
-
Parasramka, M.1
Dashwood, W.M.2
Wang, R.3
Saeed, H.H.4
Williams, D.E.5
Ho, E.6
|